Lectures

Earning CPD by listening to Healthed podcasts is simple. Each episode is eligible for Educational Activities CPD.

Dr Shannon Thomas

Dr Shannon Thomas explains that the key to better health outcomes is suspecting the condition, investigating early and knowing when and how to treat.

Dr Rupert Hinds

Dr Rupert Hinds explains the management of common functional gastrointestinal disorders in infants

A/Prof Alex Polyakov

A/Prof Alex Polyakov explores the various symptoms associated with fibroids.

Prof Richard O'Brien

Prof Richard O'Brien, explains that diabetic retinopathy is a common but often very manageable complication of diabetes, provided it is detected early.

A/Prof Michael Woodward AM

A/Prof Michael Woodward AM outlines the challenges associated with getting older people optimally protected.

Dr Kerry Hancock

Dr Kerry Hancock gives a very practical, case-based explanation of where LAMAs fit into a patient's asthma management.

Prof Sonia Grover

In this Healthed lecture, Prof Sonia Grover advises how to best assess and categorise the various symptoms and signs of paediatric and adolescent vulval disorders.

A/Prof Samantha Hocking

In this Healthed lecture, A/Prof Samantha Hocking provides an update on what this new treatment is.

Prof Frank Vajda AM

In this Healthed lecture, Prof Frank Vajda AO outlines the most important considerations when managing women of child-bearing age who have epilepsy.

Prof Richard Harvey

The latest understanding of the condition - pathogenesis, distinguishing features and the most accurate way to diagnose and determine its severity.

A/Prof Dion Forstner & Dr Farshad Kasraei

In this Healthed lecture, A/Prof Dion Forstner & Dr Farshad Kasraei explain that radiation therapy is the most effective non-invasive option for keratinocyte cancer lesions, with 5-year control rates approaching surgery. It also complements surgery well in the adjuvant setting for high-risk disease. Advances in technology and an understanding of radiobiological processes has allowed it to be applied to a wider variety of disease presentations, whilst mitigating acute and chronic side effects.

Prof Tony Cunningham AO

Which immunocompromised patients should be given the recombinant (Shingrix) vs the inactivated (Zostavax)- different approaches to vaccination choice.